CHINA PHARMA HOLDINGS, INC. (CPHI) Gross margin 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) gross margin by fiscal year — reported gross profit divided by reported revenue.
-3.2%FY2025 · since FY2016: 20.7% → -3.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3.2% | +40.7 pp |
| FY2024 | -43.8% | -39.8 pp |
| FY2023 | -4.0% | +2.1 pp |
| FY2022 | -6.1% | -9.7 pp |
| FY2021 | 3.6% | -14.3 pp |
| FY2020 | 18.0% | +4.4 pp |
| FY2019 | 13.6% | -2.4 pp |
| FY2018 | 16.0% | -2.7 pp |
| FY2017 | 18.7% | -2.0 pp |
| FY2016 | 20.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPHI financial trends
CPHI RevenueCPHI Net incomeCPHI Net marginCPHI Gross profitCPHI Operating incomeCPHI Operating marginCPHI Operating cash flowCPHI Free cash flowCPHI Capital expendituresCPHI Return on equityCPHI Stock buybacksCPHI Dividends paidCPHI Total assetsCPHI Total liabilitiesCPHI Shareholders’ equityCPHI overview →